[1]
Chou KC. An insightful 10-year recollection since the emergence of the 5-steps rule. Curr Pharm Des 2019; 25(40): 4223-34.
[2]
Dong Y, Qu X, Wu G, et al. Advances in the detection, mechanism and therapy studies of chronic kidney disease. Curr Pharm Des 2019; 25(40): 4235-50.
[3]
Zhang Y, Liu Z. Oncolytic virotherapy for malignant tumor: current clinical status. Curr Pharm Des 2019; 25(40): 4251-63.
[4]
Zhou G, Zhao M, Liang R, et al. Study of mechanism on binding between neratinib and MAD2L1 based on molecule simulation and multi-spectroscopy methods. Curr Pharm Des 2019; 25(40): 4287-95.
[5]
Zhang D, Guan Z-X, Zhang Z-M, et al. Recent development of computational predicting bioluminescent proteins. Curr Pharm Des 2019; 25(40): 4264-73.
Current Pharmaceutical Design
Title:Advancement of Technology for Precision Medicine
Volume: 25 Issue: 40
Author(s): Bing Niu
Affiliation:
Export Options
About this article
Cite this article as:
Niu Bing , Advancement of Technology for Precision Medicine, Current Pharmaceutical Design 2019; 25 (40) . https://dx.doi.org/10.2174/138161282540191230093056
DOI https://dx.doi.org/10.2174/138161282540191230093056 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals Recent Patents for Predictive and Prognostic Biomarkers in Non-Small-Cell Lung Cancer
Recent Patents on Biomarkers The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
Current Pharmaceutical Design Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview
Current Drug Metabolism Electric cable: cytoskeleton as an electric transmitter for cancer therapy
Current Signal Transduction Therapy A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Current Cancer Drug Targets Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design Dendritic Cell Immunotherapy for Melanoma
Reviews on Recent Clinical Trials Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Current Drug Targets Antiviral Immunotherapy for Mosquito-Borne Flaviviruses: A Review of Current Status
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Novel Method for Screening of Anti-Cancer Drugs: Availability of Screening in Acidic Medium
Recent Patents on Biomedical Engineering (Discontinued) The Endothelin Axis as Therapeutic Target in Human Malignancies: Present and Future
Current Pharmaceutical Design Recent Advances in Herbal Nanomedicines for Cancer Treatment
Current Molecular Pharmacology Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Current Drug Targets IDO+ DCs and Signalling Pathways
Current Cancer Drug Targets Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin
Anti-Cancer Agents in Medicinal Chemistry LASP1 in Tumor and Tumor Microenvironment
Current Molecular Medicine